Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Assets (2016 - 2025)

Ocular Therapeutix has reported Return on Assets over the past 12 years, most recently at 0.43% for Q4 2025.

  • Quarterly results put Return on Assets at 0.43% for Q4 2025, down 8.0% from a year ago — trailing twelve months through Dec 2025 was 0.43% (down 8.0% YoY), and the annual figure for FY2025 was 0.42%, up 5.0%.
  • Return on Assets for Q4 2025 was 0.43% at Ocular Therapeutix, up from 0.57% in the prior quarter.
  • Over the last five years, Return on Assets for OCUL hit a ceiling of 0.22% in Q2 2024 and a floor of 0.71% in Q2 2023.
  • Median Return on Assets over the past 5 years was 0.43% (2023), compared with a mean of 0.44%.
  • Biggest five-year swings in Return on Assets: surged 88bps in 2021 and later decreased -30bps in 2025.
  • Ocular Therapeutix's Return on Assets stood at 0.4% in 2021, then crashed by -38bps to 0.55% in 2022, then rose by 21bps to 0.43% in 2023, then grew by 20bps to 0.35% in 2024, then fell by -24bps to 0.43% in 2025.
  • The last three reported values for Return on Assets were 0.43% (Q4 2025), 0.57% (Q3 2025), and 0.52% (Q2 2025) per Business Quant data.